The deal size was increased to $125M in common stock from $75M in common stock. JPMorgan acted as sole book running manager for the offering.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on STOK:
- Stoke Therapeutics announces $75M common stock offering
- Stoke Therapeutics price target raised to $17 from $13 at Wedbush
- Stoke Therapeutics price target raised to $22 from $14 at Needham
- Stoke Therapeutics price target raised to $21 from $18 at Canaccord
- Stoke Therapeutics reports Q4 EPS (60c), consensus (63c)